Strides Pharma Science

From Wikipedia, the free encyclopedia

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Strides Pharma Science" – news · newspapers · books · scholar · JSTOR (December 2024) (Learn how and when to remove this message)

Strides Pharma Science


Company type	Public
Traded as	NSE: STRIDES BSE: 532531
Industry	Pharmaceutical
Founded	1990
Headquarters	Bannerghatta Road, Bangalore, India
Key people	Arun Kumar (Founder and Chairman)
Products	Hard gelatin, solid dosage, Tablets, Formulations
Revenue	$566 million (2014)^[1]
Website	www.strides.com

Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies^[which?] to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.

Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab.^[2] In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.^[3]

Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception.^[4]

Manufacturing

Indian plants

In India the company operates eight pharmaceutical plants:

KRSG Anekal - The company has a manufacturing plant at Jigani in the taluka of Anekal in the southern part of the Bangalore metropolitan area. The plant makes soft gelatin capsules, hard gelatin capsules, tablets and ointments.
STAR - Strides Technology & Research - the R&D centre at Bannerghata Road (opp. IIM-B, Bangalore)

On 5 December 2013, the company announced that it had completed the sale of its Agila Specialties Division to Mylan Inc., for a total sum of up to US$1.75 billion.^{[citation needed]}

Non-Indian plants

Europe - Italy (Beltapharm S.pA)

Global Disease Initiative

Strides operates in the international market for generics to fight HIV/ AIDS, TB and malaria. The company works with the Clinton Foundation to supply lower cost anti-retroviral drugs for the treatment of HIV/AIDS as part of the Clinton Foundation's HIV/AIDS initiative. The company is also on the list of World Health Organization pre-qualified suppliers to supply generic fixed dose combination of anti-HIV drugs. It is an approved supplier to the World Bank, the African Development Bank, PEPFAR President's Emergency Plan For AIDS Relief and UNICEF.

References

^ "Strategy to delivery" (PDF). Archived from the original (PDF) on 4 April 2015.
^ PTI (19 November 2015). "Strides Arcolab changes name to Strides Shasun Ltd". Business Standard. Retrieved 6 August 2018.
^ Shasun Pharmaceuticals to merge with Strides Arcolab
^ Arun Kumar aims to reinvent Strides Arcolab with eye on new opportunities

External links

Official website

Categories:

Hidden categories: